Literature DB >> 24832146

System Strategies for Colorectal Cancer Screening at Federally Qualified Health Centers.

Jeanette M Daly1, Barcey T Levy, Carol A Moss, Camden P Bay.   

Abstract

Objectives. We assessed the protocols and system processes for colorectal cancer (CRC) screening at federally qualified health centers (FQHCs) in 4 midwestern states. Methods. We identified 49 FQHCs in 4 states. In January 2013, we mailed their medical directors a 49-item questionnaire about policies on CRC screening, use of electronic medical records, types of CRC screening recommended, clinic tracking systems, referrals for colonoscopy, and barriers to providing CRC. Results. Forty-four questionnaires (90%) were returned. Thirty-three of the respondents (75%) estimated the proportion of their patients up-to-date with CRC screening, with a mean of 35%. One major barrier to screening was inability to provide colonoscopy for patients with a positive fecal occult blood test (59%). The correlation of system strategies and estimated percentage of patients up-to-date with CRC screening was 0.43 (P = .01). Conclusions. CRC system strategies were associated with higher CRC screening rates. Implementing system strategies for CRC screening takes time and effort and is important to maintain, to help prevent, or to cure many cases of CRC, the second leading cause of cancer in the United States.

Entities:  

Year:  2015        PMID: 24832146      PMCID: PMC4250445          DOI: 10.2105/AJPH.2013.301790

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  27 in total

Review 1.  Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

2.  Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices.

Authors:  Barcey T Levy; Jeanette M Daly; Yinghui Xu; John W Ely
Journal:  J Am Board Fam Med       Date:  2012 Jan-Feb       Impact factor: 2.657

3.  Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000.

Authors:  Arti Parikh-Patel; Janet H Bates; Sharan Campleman
Journal:  Cancer       Date:  2006-09-01       Impact factor: 6.860

4.  Empirically identified goals for the management of unexplained symptoms.

Authors:  Terri A Nordin; Arthur J Hartz; Russell Noyes; Matthew C Anderson; Marcy E Rosenbaum; Paul A James; John W Ely; Neeraj Agarwal; Barcey T Levy
Journal:  Fam Med       Date:  2006 Jul-Aug       Impact factor: 1.756

5.  Trends in colorectal cancer test use among vulnerable populations in the United States.

Authors:  Carrie N Klabunde; Kathleen A Cronin; Nancy Breen; William R Waldron; Anita H Ambs; Marion R Nadel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-08       Impact factor: 4.254

6.  Systems strategies to support cancer screening in U.S. primary care practice.

Authors:  K Robin Yabroff; Jane Zapka; Carrie N Klabunde; Gigi Yuan; Dennis W Buckman; David Haggstrom; Steven B Clauser; Jacqueline Miller; Stephen H Taplin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-05       Impact factor: 4.254

7.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

Review 8.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

9.  Colorectal cancer screening among users of county health centers and users of private physician practices.

Authors:  Catherine R Messina; Dorothy S Lane; Roberto C Colson
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

10.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  14 in total

1.  Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.

Authors:  Barcey T Levy; Camden Bay; Yinghui Xu; Jeanette M Daly; George Bergus; Jeffrey Dunkelberg; Carol Moss
Journal:  J Med Screen       Date:  2014-06-23       Impact factor: 2.136

2.  A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.

Authors:  Stacy N Davis; Shannon M Christy; Enmanuel A Chavarria; Rania Abdulla; Steven K Sutton; Alyssa R Schmidt; Susan T Vadaparampil; Gwendolyn P Quinn; Vani N Simmons; Chukwudi B Ufondu; Chitra Ravindra; Ida Schultz; Richard G Roetzheim; David Shibata; Cathy D Meade; Clement K Gwede
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

3.  Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion.

Authors:  Nathalie Huguet; Heather Angier; Rebecca Rdesinski; Megan Hoopes; Miguel Marino; Heather Holderness; Jennifer E DeVoe
Journal:  Prev Med       Date:  2019-05-08       Impact factor: 4.018

4.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

Review 5.  Characteristics of Effective Colorectal Cancer Screening Navigation Programs in Federally Qualified Health Centers: A Systematic Review.

Authors:  Jermy-Leigh B Domingo; Kathryn L Braun
Journal:  J Health Care Poor Underserved       Date:  2017

6.  Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Authors:  Carrie M Nielson; William M Vollmer; Amanda F Petrik; Erin M Keast; Beverly B Green; Gloria D Coronado
Journal:  J Gen Intern Med       Date:  2019-01-25       Impact factor: 5.128

7.  Use of Evidence-Based Interventions and Implementation Strategies to Increase Colorectal Cancer Screening in Federally Qualified Health Centers.

Authors:  Swann Arp Adams; Catherine L Rohweder; Jennifer Leeman; Daniela B Friedman; Ziya Gizlice; Robin C Vanderpool; Natoshia Askelson; Alicia Best; Susan A Flocke; Karen Glanz; Linda K Ko; Michelle Kegler
Journal:  J Community Health       Date:  2018-12

8.  Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods.

Authors:  Amanda F Petrik; Beverly Green; Jennifer Schneider; Edward J Miech; Jennifer Coury; Sally Retecki; Gloria D Coronado
Journal:  J Gen Intern Med       Date:  2020-10-26       Impact factor: 5.128

9.  Assessing Levels and Correlates of Implementation of Evidence-Based Approaches for Colorectal Cancer Screening: A Cross-Sectional Study With Federally Qualified Health Centers.

Authors:  Timothy J Walker; Betsy Risendal; Michelle C Kegler; Daniela B Friedman; Bryan J Weiner; Rebecca S Williams; Shin-Ping Tu; Maria E Fernandez
Journal:  Health Educ Behav       Date:  2018-07-10

10.  Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol.

Authors:  Barcey T Levy; Jeanette M Daly; Yinghui Xu; Seth D Crockett; Richard M Hoffman; Jeffrey D Dawson; Kim Parang; Navkiran K Shokar; Daniel S Reuland; Marc J Zuckerman; Avraham Levin
Journal:  Contemp Clin Trials       Date:  2021-05-08       Impact factor: 2.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.